MP1-11 VALIDATION OF THE DECIPHER® PROSTATE CANCER CLASSIFIER IN INTERMEDIATE TO HIGH RISK MEN TREATED WITH RADICAL PROSTATECTOMY BUT WITHOUT ADDITIONAL THERAPY UPON PSA RISE